Select Reports


Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. (NASDAQ: TERN) is a clinical-stage biopharmaceutical company that develops drugs and therapies to treat liver diseases.

Broker Recommendations

29-12-22 U.S. RESEARCH ROUNDUP-Getarou… Reuters

Related News

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy and
Terms and Conditions
Allow cookies Decline